![Pulmonx Corporation logo](/logos/LUNG.webp)
Pulmonx Corporation
NASDAQ:LUNG
Overview | Financials
Company Name | Pulmonx Corporation |
Symbol | LUNG |
Currency | USD |
Price | 7.31 |
Market Cap | 286,205,506 |
Dividend Yield | 0% |
52-week-range | 5.46 - 14.835 |
Industry | Medical Devices |
Sector | Healthcare |
CEO | Mr. Glendon E. French |
Website | https://pulmonx.com |
An error occurred while fetching data.
About Pulmonx Corporation
Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a balloon catheter and console system
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD